Nu Skin Enterprises, Inc. (NYSE: NUS) stock fell -2.61% on Monday to $17.53 against a previous-day closing price of $18.00. With 0.56 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.58 million shares. During the session, the Household & Personal Products company that operates in wider Consumer Defensive sector, reached to the highest price of $17.93 whereas the lowest price it dropped to was $17.36. The 52-week range on NUS shows that it touched its highest point at $45.55 and its lowest point at $16.15 during that stretch. It currently has a 1-year price target of $21.00. With its current market cap of 866.16 million, NUS has annualized dividend of $1.56 while the current yield stands at 8.90%. Beta for the stock currently stands at 1.15.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NUS was up-trending over the past week, with a rise of 7.35%, but this was down by -10.15% over a month. Three-month performance dropped to -27.02% while six-month performance fell -50.84%. The stock lost -53.64% in the past year, while it has lost -58.42% so far this year. A look at the trailing 12-month EPS for NUS yields 1.17 with Next year EPS estimates of 2.12. For the next quarter, that number is 0.13. This implies an EPS growth rate of -57.73% for this year and 142.29% for next year. EPS is expected to grow by 6.81% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -2.55%.
Float and Shares Shorts:
At present, 49.50 million NUS shares are outstanding with a float of 48.62 million shares on hand for trading. On Oct 30, 2023, short shares totaled 2.3 million, which was 4.65% higher than short shares on Sep 28, 2023. In addition to Mr. Steven J. Lund as the firm’s Executive Chairman of the Board, Mr. Ryan S. Napierski serves as its President, CEO & Director.
Through their ownership of 92.57% of NUS’s outstanding shares, institutional investors have majority control over the company.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NUS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With NUS analysts setting a high price target of $25.00 and a low target of $18.00, the average target price over the next 12 months is $21.00. Based on these targets, NUS could surge 42.61% to reach the target high and rise by 2.68% to reach the target low. Reaching the average price target will result in a growth of 19.79% from current levels.
Summary of Insider Activity:
Insiders traded NUS stock several times over the past three months with 1 Buys and 4 Sells. In these transactions, 27 shares were bought while 12,068 shares were sold. The number of buy transactions has increased to 30 while that of sell transactions has risen to 38 over the past year. The total number of shares bought during that period was 426,356 while 264,661 shares were sold.